Company news
TScan Therapeutics, Inc. news in 2021
TScan Therapeutics, Inc.'s news releases, calls and decks from 2021, newest first.
TScan Therapeutics Announces Poster Presentations at the 63rd American Society of Hematology Annual Meeting and Exposition
December 12, 2021
TScan Therapeutics Establishes Facility to Manufacture T Cell Receptor Engineered T Cell Therapies
December 1, 2021
TScan Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Company Progress
November 9, 2021
TScan Therapeutics Announces Upcoming Presentations at the 63rd American Society of Hematology Annual Meeting and Exposition
November 3, 2021
TScan Therapeutics Appoints Heather Savelle as Vice President, Investor Relations
October 4, 2021
TScan Therapeutics Appoints Zoran Zdraveski, J.D., Ph.D. as Chief Legal Officer
September 8, 2021
TScan Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress
August 18, 2021
TScan Therapeutics, Inc. Announces Pricing of Initial Public Offering
July 14, 2021